China Healthwise Holdings Limited (0348.HK)
HKD 0.1
(6.45%)
HKD 0.1
(6.45%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -117.45 Million HKD | -1291.48% |
| 2022 | -45.8 Million HKD | -124.78% |
| 2021 | -89.97 Million HKD | 142.75% |
| 2020 | -45.33 Million HKD | 219.33% |
| 2019 | -10.7 Million HKD | -3884.21% |
| 2018 | 283 Thousand HKD | 100.42% |
| 2017 | -107.87 Million HKD | 64.75% |
| 2016 | -242.71 Million HKD | -141.16% |
| 2015 | -83.8 Million HKD | -596.8% |
| 2014 | -15.08 Million HKD | 85.64% |
| 2013 | 8.68 Million HKD | 47.78% |
| 2012 | 5.87 Million HKD | -96.65% |
| 2011 | 83.17 Million HKD | 333.93% |
| 2010 | -154.65 Million HKD | 20.74% |
| 2009 | -114.27 Million HKD | 46.15% |
| 2008 | -219.85 Million HKD | -353.46% |
| 2007 | 69.24 Million HKD | 82.91% |
| 2006 | 38.98 Million HKD | -2.79% |
| 2005 | 38.94 Million HKD | 8.46% |
| 2004 | 35.9 Million HKD | -39.58% |
| 2003 | 110.85 Million HKD | 12.51% |
| 2002 | 52.82 Million HKD | 5.9% |
| 2001 | 49.87 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -6.5 Million HKD | 93.18% |
| 2024 Q2 | -6.5 Million HKD | 0.0% |
| 2023 Q3 | -57.93 Million HKD | -161.1% |
| 2023 FY | - HKD | -1291.48% |
| 2023 Q1 | 1.83 Million HKD | 106.89% |
| 2023 Q2 | -22.19 Million HKD | -1306.31% |
| 2023 Q4 | -84.77 Million HKD | -46.32% |
| 2022 Q2 | -8.39 Million HKD | -139.28% |
| 2022 Q3 | -15.59 Million HKD | -85.74% |
| 2022 FY | - HKD | -124.78% |
| 2022 Q1 | -3.5 Million HKD | 96.45% |
| 2022 Q4 | -26.68 Million HKD | -71.15% |
| 2021 Q4 | -98.77 Million HKD | -93.77% |
| 2021 FY | - HKD | 142.75% |
| 2021 Q1 | 13.23 Million HKD | 132.77% |
| 2021 Q2 | 27.18 Million HKD | 105.39% |
| 2021 Q3 | -50.97 Million HKD | -287.51% |
| 2020 Q2 | -3.17 Million HKD | -5867.27% |
| 2020 Q4 | -40.38 Million HKD | 0.0% |
| 2020 Q1 | 55 Thousand HKD | 0.0% |
| 2020 FY | - HKD | 219.33% |
| 2019 FY | - HKD | -3884.21% |
| 2019 Q1 | -15.94 Million HKD | 0.0% |
| 2018 Q3 | 26.97 Million HKD | 47.11% |
| 2018 Q1 | 15.82 Million HKD | 181.26% |
| 2018 FY | - HKD | 100.42% |
| 2018 Q2 | 18.33 Million HKD | 15.83% |
| 2017 Q4 | -19.47 Million HKD | -31.11% |
| 2017 FY | - HKD | 64.75% |
| 2017 Q2 | -14.85 Million HKD | 75.2% |
| 2017 Q1 | -59.91 Million HKD | 0.0% |
| 2017 Q3 | -14.85 Million HKD | 0.0% |
| 2016 Q3 | -15.08 Million HKD | 0.0% |
| 2016 Q1 | -19.99 Million HKD | 0.0% |
| 2016 Q4 | -59.91 Million HKD | -297.25% |
| 2016 Q2 | -15.08 Million HKD | 24.56% |
| 2016 FY | - HKD | -141.16% |
| 2015 Q2 | -15.26 Million HKD | -240.77% |
| 2015 Q3 | -15.26 Million HKD | 0.0% |
| 2015 Q4 | -19.99 Million HKD | -30.98% |
| 2015 Q1 | -4.47 Million HKD | 0.0% |
| 2015 FY | - HKD | -596.8% |
| 2014 Q4 | -4.47 Million HKD | -46.18% |
| 2014 Q2 | -3.06 Million HKD | 38.55% |
| 2014 Q3 | -3.06 Million HKD | 0.0% |
| 2014 FY | - HKD | 85.64% |
| 2014 Q1 | -4.98 Million HKD | 0.0% |
| 2013 Q2 | -1.06 Million HKD | -169.49% |
| 2013 Q4 | -4.98 Million HKD | -367.29% |
| 2013 Q1 | 1.53 Million HKD | 0.0% |
| 2013 Q3 | -1.06 Million HKD | 0.0% |
| 2013 FY | - HKD | 47.78% |
| 2012 Q3 | 1.43 Million HKD | 0.0% |
| 2012 FY | - HKD | -96.65% |
| 2012 Q4 | 1.53 Million HKD | 7.15% |
| 2012 Q1 | 967.5 Thousand HKD | 0.0% |
| 2012 Q2 | 1.43 Million HKD | 48.11% |
| 2011 Q3 | - HKD | 0.0% |
| 2011 Q4 | 967.5 Thousand HKD | 0.0% |
| 2011 Q1 | - HKD | 0.0% |
| 2011 FY | - HKD | 333.93% |
| 2010 Q1 | - HKD | 0.0% |
| 2010 FY | - HKD | 20.74% |
| 2010 Q3 | - HKD | 0.0% |
| 2009 Q1 | - HKD | 0.0% |
| 2009 FY | - HKD | 46.15% |
| 2008 FY | - HKD | -353.46% |
| 2007 FY | - HKD | 82.91% |
| 2006 FY | - HKD | -2.79% |
| 2005 FY | - HKD | 8.46% |
| 2004 FY | - HKD | -39.58% |
| 2003 FY | - HKD | 12.51% |
| 2002 FY | - HKD | 5.9% |
| 2001 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Tycoon Group Holdings Limited | 147.38 Million HKD | 179.69% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 779.54 Million HKD | 115.067% |